• Johns Hopkins University
    $900,000 through June, 2019

    to identify lipid biomarkers of progressive MS.

    Multiple Sclerosis USA Awarded: November, 2014
  • J. David Gladstone Institutes
    $495,000 through June, 2017

    to explore the potential of the coagulation cascade as a unique niche for biomarkers in progressive Multiple Sclerosis.

    Multiple Sclerosis USA Awarded: November, 2014
  • Salk Institute for Biological Studies
    $900,000 through December, 2017

    to develop in vitro models to study subtypes of MS using human cells.

    Multiple Sclerosis USA Awarded: November, 2014
  • National Multiple Sclerosis Society, Southern California & Nevada Chapter
    $1,100,000 through December, 2022

    for the Fast Forward Fund, which funds pharmaceutical and biotechnology companies developing innovative therapeutics and diagnostic strategies for Multiple Sclerosis.

    Multiple Sclerosis USA Awarded: November, 2014
  • National Multiple Sclerosis Society, Southern California & Nevada Chapter
    $1,000,000 through September, 2018

    to fund a cost-benefit analysis of current Multiple Sclerosis Adult Day Programs.

    Multiple Sclerosis USA Awarded: November, 2014
  • Foundation for the National Institutes of Health
    $4,000 through November, 2015

    to fund MS research at the Translational Neuroradiology Unit of NINDS.

    Multiple Sclerosis USA Awarded: November, 2014
  • Myelin Repair Foundation
    $1,350,000 through August, 2017

    to provide flexible funding for Myelin Repair Foundation-sponsored research and to build fundraising capacity.

    Multiple Sclerosis USA Awarded: August, 2014
  • National Multiple Sclerosis Society, Southern California & Nevada Chapter
    $200 through December, 2014

    to support the Bike MS Coastal Challenge 2013.

    Multiple Sclerosis USA Awarded: December, 2013
  • University of California, San Francisco
    $885,000 through May, 2017

    for a digital portal that manages, accesses, and displays multi-dimensional patient information in a tablet application that quantifies clinical outcomes and predicts disease trajectories for MS patients.

    Multiple Sclerosis USA Awarded: November, 2013
  • The Regents of the University of California
    $1,600,000 through November, 2015

    to establish a disability specific pipeline to develop generic, inexpensive neuroprotective drugs to halt progression of specific disabilities related to MS.

    Multiple Sclerosis USA Awarded: November, 2013